Apr 21, 2014
Evacetrapib, LY2484595 for Treatment of high cholesterol and preventing cardiac events
Evacetrapib, LY2484595
Evacetrapib, LY2484595
Evacetrapib is an experimental drug being investigated to raise high-density lipoprotein cholesterol (HDL-C) via inhibition of the cholesteryl ester transfer protein (CETP)
Trans-4-({(5S)-5-[{[3,5-bis(trifluoromethyl)phenyl]methyl}(2-methyl-2H-tetrazol-5- yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzazepin-1-yl}methyl) cyclohexanecarboxylic acid
trans-4-[[(5S)-5-[[[3…
View On WordPress